|
業務類別
|
Biotechnology |
|
業務概覽
|
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in theapplication of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. |
| 公司地址
| 1 Controls Drive, Shelton, CT, USA, 06484 |
| 電話號碼
| +1 203 937-6137 |
| 傳真號碼
| +1 203 859-5095 |
| 公司網頁
| https://www.nanoviricides.com |
| 員工數量
| 7 |
| Dr. Anil R. Diwan, PhD |
Principal Executive Officer, Chairman of the Board and President |
美元 400.00K |
08/10/2025 |
| Ms. Meeta Vyas, M.B.A.,S.B. |
Chief Financial Officer and Principal Accounting Officer |
美元 129.60K |
08/10/2025 |
|
|
| Mr. Brian Zucker, C.P.A. |
Independent Director |
08/10/2025 |
| Dr. Anil R. Diwan, PhD |
Principal Executive Officer, Chairman of the Board and President |
08/10/2025 |
| Dr. Makarand Jawadekar, PhD |
Independent Director |
08/10/2025 |
| Mr. Theodore Edward Rokita, Esq. |
Independent Director |
08/10/2025 |
|
|
|
|
